Integrated Diagnostics (OTCMKTS:IDGXF – Get Free Report) is expected to announce its resultson Thursday, April 16th. Analysts expect the company to announce earnings of ($0.0112) per share and revenue of $75.4370 million for the quarter.
Integrated Diagnostics Stock Performance
OTCMKTS IDGXF opened at $0.64 on Thursday. Integrated Diagnostics has a twelve month low of $0.45 and a twelve month high of $0.70. The stock has a fifty day simple moving average of $0.64 and a 200 day simple moving average of $0.62.
About Integrated Diagnostics
Integrated Diagnostics Holdings PSC (OTCMKTS: IDGXF) is a leading provider of diagnostic services in the United Arab Emirates and the broader Gulf Cooperation Council (GCC) region. Headquartered in Abu Dhabi, the company operates an extensive network of pathology laboratories and radiology facilities, offering a comprehensive suite of clinical testing and medical imaging services. Its offerings span routine laboratory tests, advanced molecular diagnostics, histopathology, and a range of radiological modalities such as MRI, CT, ultrasound, and X-ray.
Since its founding in 1993, Integrated Diagnostics has expanded its footprint across the UAE, with patient service centers and lab collection points in Abu Dhabi, Dubai, and the Northern Emirates.
Featured Stories
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
